- PR Newswire•3 days ago
SAN DIEGO, April 21, 2017 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that the Special Meeting of Stockholders held earlier today was convened and adjourned without any business ...
- PR Newswire•4 days ago
Mast Therapeutics Announces Possible Adjournment Of Special Stockholders Meeting To Solicit Additional Votes For Merger With Savara
If adjourned, Mast expects to reconvene the special meeting on Thursday, April 27, 2017 at 9:00 a.m., local time, at the same location, 3611 Valley Centre Drive, Suite 500, San Diego, California 92130. Mast does not anticipate any change in the record date for stockholders entitled to vote at the special meeting. "We appreciate that so many of Mast's stockholders have voted overwhelmingly in favor of the merger with Savara.
- PR Newswire•7 days ago
"The overwhelming majority of Mast stockholders who have submitted their votes have voted in favor of the merger. However, more votes are needed to meet the required threshold for the merger to be completed," stated Brian M. Culley, Chief Executive Officer of Mast. "Mast has more than 30,000 stockholders and many of them hold relatively small positions.
MSTX : Summary for Mast Therapeutics, Inc. Common - Yahoo Finance
Mast Therapeutics, Inc. (MSTX)
NYSE MKT - Nasdaq Real Time Price. Currency in USD
Add to watchlist
|Day's Range||0.13 - 0.14|
|52 Week Range||0.07 - 0.71|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.78|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|